ASPIRIN RESISTANCE 11-DEHYDROTHROMBOXANE B2 Test
Test Name: ASPIRIN RESISTANCE 11-DEHYDROTHROMBOXANE B2 Test
Components: Price: 2750.0 AED
Sample Condition: 5 mL (4 mL min.) urine in a special culture vacutainer tube available from LPL. Ship refrigerated or frozen. Duly filled Test Send Out Consent Form is mandatory.
Report Delivery: Sample by 7th of the month; Report after 2-3 weeks
Method: Immunoassay
Test type: Heart Diseases
Doctor: Physician
Test Department: OS
Pre Test Information: Duly filled Test Send Out Consent Form is mandatory.
Test Details
The ASPIRIN RESISTANCE (11-DEHYDROTHROMBOXANE B2) test is a laboratory test used to determine if an individual is resistant to the effects of aspirin. Aspirin is commonly prescribed to prevent blood clot formation and reduce the risk of heart attacks and strokes. However, some individuals may not respond to aspirin treatment due to aspirin resistance.
The test measures the level of 11-dehydrothromboxane B2 (11-dTXB2) in the blood or urine. Thromboxane is a substance that promotes blood clotting, and aspirin works by inhibiting its production. Therefore, a high level of 11-dTXB2 indicates that aspirin is not effectively inhibiting thromboxane production, suggesting aspirin resistance.
The test is typically performed in individuals who are not responding to aspirin therapy, despite taking the recommended dosage. It can help identify patients who may require alternative antiplatelet medications or higher doses of aspirin.
It is important to note that aspirin resistance is not a well-defined condition, and its clinical significance is still a subject of debate. Some studies suggest that aspirin resistance may be associated with an increased risk of cardiovascular events, while others do not find a significant correlation.
If you suspect aspirin resistance or have concerns about your response to aspirin therapy, it is recommended to consult with a healthcare professional who can evaluate your specific situation and provide appropriate guidance.
Test Name | ASPIRIN RESISTANCE 11-DEHYDROTHROMBOXANE B2 Test |
---|---|
Components | |
Price | 2750.0 AED |
Sample Condition | 5 mL (4 mL min.) urine in a special culture vacutainer tube available from LPL. Ship refrigerated or frozen. Duly filled Test Send Out Consent Formis mandatory. |
Report Delivery | Sample by 7th of the month; Report after 2-3 weeks |
Method | Immunoassay |
Test type | Heart Diseases |
Doctor | Physician |
Test Department: | OS |
Pre Test Information | Duly filled Test Send Out Consent Formis mandatory. |
Test Details | The ASPIRIN RESISTANCE (11-DEHYDROTHROMBOXANE B2) test is a laboratory test used to determine if an individual is resistant to the effects of aspirin. Aspirin is commonly prescribed to prevent blood clot formation and reduce the risk of heart attacks and strokes. However, some individuals may not respond to aspirin treatment due to aspirin resistance. The test measures the level of 11-dehydrothromboxane B2 (11-dTXB2) in the blood or urine. Thromboxane is a substance that promotes blood clotting, and aspirin works by inhibiting its production. Therefore, a high level of 11-dTXB2 indicates that aspirin is not effectively inhibiting thromboxane production, suggesting aspirin resistance. The test is typically performed in individuals who are not responding to aspirin therapy, despite taking the recommended dosage. It can help identify patients who may require alternative antiplatelet medications or higher doses of aspirin. It is important to note that aspirin resistance is not a well-defined condition, and its clinical significance is still a subject of debate. Some studies suggest that aspirin resistance may be associated with an increased risk of cardiovascular events, while others do not find a significant correlation. If you suspect aspirin resistance or have concerns about your response to aspirin therapy, it is recommended to consult with a healthcare professional who can evaluate your specific situation and provide appropriate guidance. |